Specialty Pharmacy

Methotrexate and cyclophosphamide burn excessive dietary fat.

Newly-approved nusinersen does not completely treat the muscular disorder.

Aurintricarboxylic acid blocks the spread of glioblastoma.

Top news of the day from across the health care landscape.

Large chunk of profits from prescription drug sales are going to supply chain entities and discounts.

No evidence of disease activity criteria in multiple sclerosis may need to be reconsidered.

Plant compound inhibits the metastasis of aggressive breast cancer in mice.

Combination therapy improves outcomes in cancer patients in need of an organ transplant.

High-risk family members more likely to have early subclinical manifestations of MS.

Markers identify patients who benefit from new and more aggressive prostate cancer treatments.

Small cell tumors respond differently to treatment.

Top news of the day from across the health care landscape.

The number of successful malpractice suits against pharmacists is low compared with dentists and physicians.

Measures to standardize specialty pharmacy data should be put in place to improve the industry.

The report validates the position of many industry experts that these fees, levied by pharmacy benefit managers and Part D plan sponsors, are ineffective and harmful.

Worldwide there are more than 350,000 HCV-related deaths per year.

Sheila Arquette, RPh, discusses the importance of obtaining accreditation for specialty pharmacy.

Findings opens up potential new treatments for patients with Crohn’s.

Cancer screenings do not reduce the incidence of advanced tumors.

Top news of the day from across the health care landscape.

Winners to be revealed at Asembia 2017, finalists and winners to be recognized in upcoming issues of Specialty Pharmacy Times.

Risky sexual behavior increases the rate of HIV transmission among at-risk populations.

Certain factors influence the choice of the biologic drug in RA.

Dietary regimen may prevent or delay tumor progression.

Antibody well tolerated in patients with HIV.

Patient with a failing liver who received an HCV-infected liver cured of the virus.

Physical activity can help overcome comorbidities associated with aromatase inhibitor treatment for breast cancer.

Antibody-based therapy may be a novel addition to immunotherapies for breast cancer, lung cancer, and colon cancer.